133 related articles for article (PubMed ID: 21271901)
1. Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems.
Zhong JH; Ma L; Li LQ; Ru HM; Zhao YN
Scand J Gastroenterol; 2011 Jun; 46(6):645-51. PubMed ID: 21271901
[TBL] [Abstract][Full Text] [Related]
2. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
López RL; del Muro XG
Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months.
Jiang WZ; Guan GX; Lu HS; Yang YH; Kang DY; Huang HG
J Surg Oncol; 2011 Dec; 104(7):760-4. PubMed ID: 21713778
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant imatinib therapy for gastrointestinal stromal tumors.
Pisters PW; Colombo C
J Surg Oncol; 2011 Dec; 104(8):896-900. PubMed ID: 22069174
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumours.
Connolly EM; Gaffney E; Reynolds JV
Br J Surg; 2003 Oct; 90(10):1178-86. PubMed ID: 14515284
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Cassier PA; Dufresne A; Arifi S; El Sayadi H; Labidi I; Ray-Coquard I; Tabone S; Méeus P; Ranchère D; Sunyach MP; Decouvelaere AV; Alberti L; Blay JY
Expert Opin Pharmacother; 2008 May; 9(7):1211-22. PubMed ID: 18422477
[TBL] [Abstract][Full Text] [Related]
8. The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness.
Kosmadakis N; Visvardis EE; Kartsaklis P; Tsimara M; Chatziantoniou A; Panopoulos I; Erato P; Capsambelis P
Surg Oncol; 2005 Aug; 14(2):75-84. PubMed ID: 15993051
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors.
Seshadri RA; Rajendranath R
J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360
[TBL] [Abstract][Full Text] [Related]
10. [Imatinib in the GIST therapy: ten years later].
Lopez M
Clin Ter; 2011; 162(6):563-73. PubMed ID: 22262331
[TBL] [Abstract][Full Text] [Related]
11. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumor.
Gupta P; Tewari M; Shukla HS
Surg Oncol; 2008 Aug; 17(2):129-38. PubMed ID: 18234489
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments.
Reynoso D; Trent JC
Curr Opin Oncol; 2010 Jul; 22(4):330-5. PubMed ID: 20520542
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
[TBL] [Abstract][Full Text] [Related]
15. Practical management of imatinib in gastrointestinal stromal tumors.
Barnes T; Reinke D
Clin J Oncol Nurs; 2011 Oct; 15(5):533-45. PubMed ID: 21951740
[TBL] [Abstract][Full Text] [Related]
16. Imatinib in gastrointestinal stromal tumor: does treatment duration matter?
Adenis A; Penel N; Blay JY
Oncology; 2009; 77(3-4):157-61. PubMed ID: 19729974
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial].
Zhan WH; Wang PZ; Shao YF; Wu XT; Gu J; Li R; Wan DS; Ding KF; Shi YQ; Yu JR; Lu HS; Zou XM; Bi JW; Sun YH; Lu YF; Chen DD; Zhang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):383-7. PubMed ID: 17043955
[TBL] [Abstract][Full Text] [Related]
18. Recurrence risk after resection of gastrointestinal stromal tumors: size is not all that matters... The consequences of tumor rupture.
Han D; Deneve J; Gonzalez RJ
Am Surg; 2012 Jan; 78(1):74-9. PubMed ID: 22273319
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors.
von Mehren M; Watson JC
Hematol Oncol Clin North Am; 2005 Jun; 19(3):547-64, vii. PubMed ID: 15939196
[TBL] [Abstract][Full Text] [Related]
20. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]